(Q35579403)

9 August 2017

1 reference

title

Once-daily administration of antiretrovirals: pharmacokinetics of emerging therapies (English)

1 reference

9 August 2017

1 reference

3

Gilles Peytavin

1 reference

9 August 2017

4

Jean-Michel Molina

1 reference

9 August 2017

1

Anne-Marie Taburet

1 reference

9 August 2017

author name string

Sabine Paci-Bonaventure

series ordinal

2

1 reference

9 August 2017

publication date

1 January 2003

1 reference

Clinical Pharmacokinetics

9 August 2017

published in

1 reference

9 August 2017

volume

42

1 reference

9 August 2017

issue

14

1 reference

9 August 2017

page(s)

1179-1191

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-200342140-00001

9 August 2017

exact match

0 references

cites work

Clinical pharmacokinetics of probenecid

1 reference

12 December 2020

A pilot trial of indinavir, ritonavir, didanosine, and lamivudine in a once-daily four-drug regimen for HIV infection

1 reference

12 December 2020

Pharmacokinetics, food intake requirements and tolerability of once-daily combinations of nelfinavir and low-dose ritonavir in healthy volunteers

1 reference

12 December 2020

Pharmacokinetic parameters of protease inhibitors and the Cmin/IC50 ratio: call for consensus

1 reference

12 December 2020

Comparison of the plasma pharmacokinetics and renal clearance of didanosine during once and twice daily dosing in HIV-1 infected individuals.

1 reference

12 December 2020

Tenofovir disoproxil fumarate

1 reference

12 December 2020

Virological and immunological responses to a once-a-day antiretroviral regimen with didanosine, lamivudine and efavirenz.

1 reference

12 December 2020

Lamivudine 300 mg QD versus continued lamivudine 150 mg BID with stavudine and a protease inhibitor in suppressed patients

1 reference

12 December 2020

Clinical pharmacology and pharmacokinetics of amprenavir.

1 reference

12 December 2020

Efficacy and safety of once-daily antiretroviral therapy

1 reference

12 December 2020

Basis of anti-infective therapy: pharmacokinetic-pharmacodynamic criteria and methodology for dual dosage individualisation

1 reference

12 December 2020

Didanosine once daily: potential for expanded use

1 reference

12 December 2020

Improved survival among HIV-infected individuals following initiation of antiretroviral therapy.

1 reference

12 December 2020

Comparison of the plasma pharmacokinetics of lamivudine during twice and once daily administration in patients with HIV.

1 reference

12 December 2020

Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients

1 reference

12 December 2020

Anti-human immunodeficiency virus activity and cellular metabolism of a potential prodrug of the acyclic nucleoside phosphonate 9-R-(2-phosphonomethoxypropyl)adenine (PMPA), Bis(isopropyloxymethylcarbonyl)PMPA

1 reference

12 December 2020

Safety and pharmacokinetics of once-daily regimens of soft-gel capsule saquinavir plus minidose ritonavir in human immunodeficiency virus-negative adults

1 reference

12 December 2020

Failure to maintain long-term adherence to highly active antiretroviral therapy: the role of lipodystrophy

1 reference

12 December 2020

Pharmacokinetics and potential interactions amongst antiretroviral agents used to treat patients with HIV infection

1 reference

12 December 2020

Impact of dosage frequency on patient compliance.

1 reference

12 December 2020

Therapeutic drug monitoring in HIV infection: current status and future directions

1 reference

12 December 2020

Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team

1 reference

12 December 2020

A review of low-dose ritonavir in protease inhibitor combination therapy

1 reference

12 December 2020

The steady-state pharmacokinetics of nevirapine during once daily and twice daily dosing in HIV-1-infected individuals

1 reference

12 December 2020

Didanosine dosed once daily is equivalent to twice daily dosing for patients on double or triple combination antiretroviral therapy. The AI454-147 Team

1 reference

12 December 2020

Pharmacokinetic interactions between efavirenz and rifampicin in HIV-infected patients with tuberculosis.

1 reference

12 December 2020

Once-a-day highly active antiretroviral therapy in treatment-naive HIV-1-infected adults in Senegal

1 reference

12 December 2020

Intracellular carbovir triphosphate levels in patients taking abacavir once a day.

1 reference

12 December 2020

Dose-Finding Study of Once-Daily Indinavir/Ritonavir Plus Zidovudine and Lamivudine in HIV-Infected Patients

1 reference

12 December 2020

Once-daily combination therapy with emtricitabine, didanosine, and efavirenz in human immunodeficiency virus-infected patients

1 reference

12 December 2020

Preliminary experience of adverse drug reactions, tolerability, and efficacy of a once-daily regimen of antiretroviral combination therapy

1 reference

12 December 2020

Long-term sustained delivery of 3'-azido-2',3'-dideoxythymidine in vivo by means of HA and TCP delivery devices

1 reference

12 December 2020

Tenofovir disoproxil fumarate in nucleoside-resistant HIV-1 infection: a randomized trial

1 reference

12 December 2020

Principles and practice of HIV-protease inhibitor pharmacoenhancement

1 reference

12 December 2020

Intracellular pharmacology of nucleoside analogues and protease inhibitors: role of transporter molecules

1 reference

12 December 2020

Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study

1 reference

12 December 2020

Phase II placebo-controlled trial of fozivudine tidoxil for HIV infection: pharmacokinetics, tolerability, and efficacy

1 reference

12 December 2020

Tenofovir disoproxil fumarate

1 reference

12 December 2020

Pharmacodynamics of human immunodeficiency virus type 1 protease inhibitors

1 reference

12 December 2020

Daily dosing of highly active antiretroviral therapy.

1 reference

12 December 2020

Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel

1 reference

12 December 2020

Sustained relief of chronic pain. Pharmacokinetics of sustained release morphine

1 reference

12 December 2020

Phase i/ii trial of the pharmacokinetics, safety, and antiretroviral activity of tenofovir disoproxil fumarate in human immunodeficiency virus-infected adults

1 reference

12 December 2020

Results of a phase 2 clinical trial at 48 weeks (AI424-007): a dose-ranging, safety, and efficacy comparative trial of atazanavir at three doses in combination with didanosine and stavudine in antiretroviral-naive subjects

1 reference

12 December 2020

Mechanisms of nucleoside analog antiviral activity and resistance during human immunodeficiency virus reverse transcription

1 reference

12 December 2020

Once‐a‐Day Highly Active Antiretroviral Therapy: A Systematic Review

1 reference

12 December 2020

Can HIV infection be treated successfully with a once-daily regimen?

1 reference

12 December 2020

Once-daily dosing of saquinavir and low-dose ritonavir in HIV-1-infected individuals: a pharmacokinetic pilot study

1 reference

12 December 2020

Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition

1 reference

12 December 2020

Alternative strategies for anti-HIV treatment

1 reference

12 December 2020

The VIRGO study: nevirapine, didanosine and stavudine combination therapy in antiretroviral-naive HIV-1-infected adults

1 reference

12 December 2020

Adherence to protease inhibitor therapy and outcomes in patients with HIV infection

1 reference

12 December 2020

Therapeutic drug monitoring as a tool in treating HIV infection.

1 reference

12 December 2020

The steady-state pharmacokinetics of efavirenz and nevirapine when used in combination in human immunodeficiency virus type 1-infected persons

1 reference

12 December 2020

Nevirapine/didanosine/lamivudine once daily in HIV-1-infected intravenous drug users

1 reference

12 December 2020

Simplifying protease inhibitor therapy with once-daily dosing of saquinavir soft-gelatin capsules/ritonavir (1600/100 mg): HIVNAT 001.3 study

1 reference

12 December 2020

1 reference

12 December 2020

1 reference

12 December 2020

Novel approaches for designing 5'-O-ester prodrugs of 3'-azido-2', 3'-dideoxythymidine (AZT).

1 reference

12 December 2020

Long-term patient adherence to antiretroviral therapy

1 reference

12 December 2020

The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. California Collaborative Treatment Group

1 reference

12 December 2020

10.2165/00003088-200342140-00001

Identifiers

DOI

1 reference

Dimensions Publication ID

9 August 2017

1021605953

0 references

1 reference